Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:POTP
DateTimeSourceHeadlineSymbolCompany
02/12/20083:15PMPR Newswire (US)DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of MergerNASDAQ:POTPPoint Therapeutics (MM)
02/12/20082:02PMEdgar (US Regulatory)Point Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:POTPPoint Therapeutics (MM)
02/11/20081:30PMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
02/11/20088:00AMBusiness WireUpdate on Point Therapeutics Merger with DARA BioSciencesNASDAQ:POTPPoint Therapeutics (MM)
02/08/20089:23AMEdgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
02/04/20087:36AMEdgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
02/04/20086:30AMPR Newswire (US)DARA BioSciences to Present at the ROTH Growth Stock ConferenceNASDAQ:POTPPoint Therapeutics (MM)
01/29/20083:30PMBusiness WirePoint Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with PoinNASDAQ:POTPPoint Therapeutics (MM)
01/17/20085:03AMEdgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
01/10/20081:07PMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
01/10/20087:00AMBusiness WirePoint Therapeutics Receives Additional Notice of Non-Compliance from NASDAQNASDAQ:POTPPoint Therapeutics (MM)
12/27/20072:45PMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
12/27/20072:43PMEdgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
12/27/20077:30AMBusiness WirePoint Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set forNASDAQ:POTPPoint Therapeutics (MM)
12/18/200711:55AMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
12/17/20074:12PMEdgar (US Regulatory)Point Therapeutics Inc - Registration Statement for securities to be issued in business combination transactions (S-4/A)NASDAQ:POTPPoint Therapeutics (MM)
12/17/200712:17PMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
12/17/20077:30AMBusiness WireNASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital MarketNASDAQ:POTPPoint Therapeutics (MM)
11/26/20076:13AMEdgar (US Regulatory)Point Therapeutics Inc - Securities Registration: Business Combination (S-4)NASDAQ:POTPPoint Therapeutics (MM)
11/19/200711:36AMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
11/09/20078:59AMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
11/09/20078:38AMEdgar (US Regulatory)Point Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:POTPPoint Therapeutics (MM)
10/25/20076:00AMPR Newswire (US)DARA BioSciences, Inc. Announces New Board ChairmanNASDAQ:POTPPoint Therapeutics (MM)
10/17/20076:00AMPR Newswire (US)DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License AgreementNASDAQ:POTPPoint Therapeutics (MM)
09/18/20072:36PMEdgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
08/09/20073:01PMBusiness WirePoint Therapeutics Reports Second Quarter 2007 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
07/27/20076:30AMBusiness WirePoint Therapeutics Announces Further Management ReductionsNASDAQ:POTPPoint Therapeutics (MM)
07/12/20077:30AMBusiness WirePoint Therapeutics UpdateNASDAQ:POTPPoint Therapeutics (MM)
05/31/20077:00AMBusiness WirePoint Therapeutics Reduces Costs by Cutting Work ForceNASDAQ:POTPPoint Therapeutics (MM)
05/21/20077:00AMBusiness WireTalabostat Clinical Program Put on Clinical Hold by FDANASDAQ:POTPPoint Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:POTP

Your Recent History

Delayed Upgrade Clock